Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD)

Rheumatology

Volumn 44, Issue 5, 2005, Pages 656-661

  Bodolay, E ^a   Szekanecz, Z ^a   Devenyi K ^b   Galuska, L ^a   Csipo I ^a   Vegh J ^a   Garai, I ^a   Szegedi, G ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

High resolution computed tomography; Interstitial lung disease; Lung scintigraphy; Mixed connective tissue disease

Indexed keywords

ANTIMALARIAL AGENT; CARBON MONOXIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTETATE TECHNETIUM TC 99M; SALAZOSULFAPYRIDINE; DIAGNOSTIC AGENT; GLUCOCORTICOID; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPLEMENT FIXATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEMBRANE DAMAGE; MIXED CONNECTIVE TISSUE DISEASE; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; STATISTICAL ANALYSIS; THORAX RADIOGRAPHY; TISSUE INJURY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DRUG COMBINATION; EVALUATION; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; RADIOPHARMACEUTICALS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 21244433443     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh575     Document Type: Article

References (45)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
2. Sharp GC. Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue diseases and antinuclear antibodies. Amsterdam: Elsevier, 1987:23-32.
3. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue diseases and antinuclear antibodies. Amsterdam: Elsevier, 1987:41-7.
4. Smolen JS, Steiner G. To be or not to be? Arthritis Rheum 1998;41:768-77.
5. Nedumaram, Rajendram CP, Porkodi R, Parthiban R. Mixed connective tissue disease - clinical and immunological profile. J Assoc Physicians India 2001;49:412-14.
6. Garcia-de la Torre I, Salazar-P'aramo M, Salm'on-de la Torre G. Mixed connective tissue disease. A clinico-serological study of 17 cases. Mol Biol Rep 1996;23:153-7.
7. Kitridou R, Akmal M, Turkel SB. Renal involvement in mixed connective tissue disease: A longitudinal clinicopathologic study. Semin Arthritis Rheum 1986;16:135-45.
8. Harmon C, Wolfe F, Lilard S et al. Pulmonary involvement in mixed connective tissue disease (MCTD) (abstract). Arthritis Rheum 1976;19:801.
9. Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 2001;32:69s-80s.
10. Graziano FM, Friedman LC, Grossman J. Pulmonary hypertension in a patient with mixed connective tissue disease: Clinical and pathological findings, and review of literature. Clin Exp Rheumatol 1983;1:251-5.
11. Prakash UBS. Pulmonary manifestations in mixed connective tissue disease. Semin Resp Med 1988;9:318-24.
12. Saito Y, Terada M, Takada T et al. Pulmonary involvement in mixed connective tissue disease: Comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002;26:349-57.
13. O'Doherty M, Peters AM. Pulmonary technetium-99m dietylene triamine penta-acetic acid aerosol clearance as an index of lung injury (review). Eur J Nucl Med 1997;24:81-7.
14. Alarcon-Segovia D, Villareal, M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science, 1987:33-40.
15. Davis NC, Ho M. Quantitation of immunoglobulins. In: Rose NR, Friedman H, eds. Manual of clinical immunology. Washington, DC: American Society for Microbiology, 1976:4-16.
16. Dévényi K, Czirják L. High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma. Clin Rheumatol 1995;14:633-40.
17. Wells AU, Hansell DM, Corrin B et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:738-42.
18. European Community for Coal and Steel. Standardized function testing. Report of working party on standardized lung function tests. Eur J Respir Dis 1993;6:5-52.
19. Derderian SS, Tellis CJ, Abbrecht PH, Welton RC, Rajagopal KR. Pulmonary involvement in mixed connective tissue disease. Chest 1985;88:45-8.
20. Girod CE. The lung in mixed connective tissue disease. Semin Respir Crit Care Med 1999;20:99-108.
21. Prakash EBS, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985;60:813-21.
22. Jensen GG. Reversible pulmonary hypertension in a woman with connective tissue disease. Ugeskr Laeger 1992;154:3065-6.
23. Ueda N, Mimura K, Sugiyama T, Kado T, Kobayashi K, Fukuzaki H. Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature. Virchows Arch (Pathol Anat) 1984; 404:335-40.
24. Nishimaki T, Aotsuka S, Kondo H et al. Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol 1999;26:2357-62.
25. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease. Arthritis Rheum 1999;42:899-909.
26. Grant KD, Adams LE, Hess EV. Mixed connective tissue disease - a subset with sequential clinical and laboratory features. J Rheumatol 1981;8:587-98.
27. Prakash UBS. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998;19:733-46.
28. Sharp GC, Singsen BH. Mixed connective tissue disease. In: McCarty DJ, ed. Arthritis and allied conditions: A textbook of rheumatology, 11th edn. Philadelphia: Lea and Febiger, 1989:1080-91.
29. Sullivan WD, Hurst DJ, Harmon CE, Esther JH, Agia GA et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984;63:92-107.
30. Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, du Bois RM. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1991;6:797-802.
31. Ichikado K, Johkoh T, Ikezoe J et al. Acute interstitial pneumonia: High resolution CT findings correlated with pathology. Am J Roentgenol 1997;168:333-8.
32. Remy-Jardin M, Remy J, Deffontaines C et al. Assessment of diffuse infiltrative lung disease: Comparison of conventional CT and high resolution CT. Radiology 1991;181:157-62.
33. Lee JS, IM J-G, Ahn JM et al. Fibrosing alveolitis: Prognostic implication of ground glass attenuation at high resolution CT. Radiology 1992;184:451-4.
34. Kozuka T, Johkoh T, Honda O et al. Pulmonary involvement in mixed connective tissue disease: High resolution CT findings in 41 patients. J Thorac Imag 2001;16:94-8.
35. Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, du Bois RM. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993;6:797-802.
36. Hill C, Romas E, Kirkham B. Use of sequential DTPA clearance and high resolution computerized tomography in monitoring interstitial lung disease in dermatomyositis. Br J Rheumatol 1996;35: 164-6.
37. 99mTc-DTPA aerosol scintigraphy. Nucl Med Commun 2002;23:441-6.
38. Germain MJ, Davidman M. Pulmonary hemorrhage and acute renal failure in a patient with mixed connective tissue disease. Am J Kidney Dis 1984;3:420-4.
39. Wiener-Kronish JP, Solinger AM, Warnock ML, Churg A, Ordonez N, Golden JA. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981;124:499-503.
40. Takeda T, Tsutsumi A, Ogura N et al. A case of mixed connective tissue disease with acute interstitial pneumonitis (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi 1995;18:303-7.
41. Suzuki M, Shimizu K, Sakamoto K et al. Interstitial pneumonia associated with mixed connective tissue disease. Marked improvement with azathioprine (in Japanese). Nippon Kyobu Shikkan Gakkai Zasshi 1996;34:101-5.
42. Hurst DJ, Baker WM, Gilbert G. Lung collagen synthesis and type analysis in patients with mixed connective tissue disease (MCTD). Arthritis Rheum 1980;19:801-4.
43. Hosoda T. Review of pathology of mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science, 1987:281-90.
44. Ward PA. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann NY Acad S46 1996;796:104.
45. Chouchakova N, Skokowa J, Baumann U et al. FcgRIII-mediated production of TNF-a induces immune complex alveolitis independently of CXC chemokine generation. J Immunol 2001;166: 5193-200.